- Home
- ROIV vs BROS Comparison
ROIV vs BROS Comparison
Compare ROIV & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | BROS |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 7.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ROIV | BROS |
|---|---|---|
| Price | $21.94 | $61.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 18 |
| Target Price | $21.94 | ★ $77.17 |
| AVG Volume (30 Days) | ★ 6.5M | 3.1M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.73 |
| EPS | N/A | ★ 0.51 |
| Revenue | $20,329,000.00 | ★ $1,537,335,000.00 |
| Revenue This Year | N/A | $28.73 |
| Revenue Next Year | $376.94 | $25.41 |
| P/E Ratio | ★ N/A | $120.88 |
| Revenue Growth | N/A | ★ 28.93 |
| 52 Week Low | $8.73 | $47.16 |
| 52 Week High | $22.45 | $86.88 |
Technical Indicators
Market Signals| Indicator | ROIV | BROS |
|---|---|---|
| Relative Strength Index (RSI) | 68.21 | 60.16 |
| Support Level | $20.14 | $57.30 |
| Resistance Level | $21.48 | $62.30 |
| Average True Range (ATR) | 0.66 | 2.25 |
| MACD | -0.02 | 0.38 |
| Stochastic Oscillator | 87.12 | 85.12 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.